CHEMOSENSITIZERS COUNTERACTING ACQUIRED-RESISTANCE TO ANTHRACYCLINES AND VINCA ALKALOIDS INVIVO - A NEW TREATMENT PRINCIPLE

被引：46

作者：

SKOVSGAARD, T

DANO, K

NISSEN, NI

机构：

[1] UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK

[2] UNIV COPENHAGEN, FINSEN INST, FINSEN LAB, DK-1168 COPENHAGEN, DENMARK

来源：

关键词：

D O I：

10.1016/0305-7372(84)90044-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：63 / 72

页数：10

共 87 条

[1] Arcamone F., 1981, DOXORUBICIN ANTICANC
[2] BECK WT, 1979, CANCER RES, V39, P2070
[3] CORRELATES OF VINCRISTINE RESISTANCE IN 4 MURINE TUMOR-CELL LINES
BENDER, RA
KORNREICH, WD
WODINSKY, I
[J]. CANCER LETTERS, 1982, 15 (03) : 335 - 341
[4] BIEDLER JL, 1970, CANCER RES, V30, P1174
[5] UPTAKE AND BINDING OF VINCRISTINE BY MURINE LEUKEMIA-CELLS
BLEYER, WA
FRISBY, SA
OLIVERIO, VT
[J]. BIOCHEMICAL PHARMACOLOGY, 1975, 24 (05) : 633 - 639
[6] BRAASCH W, 1961, ARZNEIMITTEL-FORSCH, V11, P336
[7] BURCHENAL JH, 1963, CANCER RES, V23, P1364
[8] CLINICAL AND PHARMACOLOGICAL IMPLICATIONS OF CANCER CELL-DIFFERENTIATION AND HETEROGENEITY
CALABRESI, P
DEXTER, DL
HEPPNER, GH
[J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) : 1933 - 1941
[9] CHERVINSKY DS, 1976, J MED, V7, P63
[10] INDUCED RESISTANCE IN LEUKEMIA-L1210 TO ADRIAMYCIN AND ITS CROSS-RESISTANCE TO VINCRISTINE AND BOUVARDIN
CHITNIS, MP
JOSHI, SS
GUDE, RP
MENON, RS
[J]. CHEMOTHERAPY, 1982, 28 (03) : 209 - 212